Microsoft partners with Novartis to bring AI to the next generation of medicines

News

Reading time icon 2 min. read

Calendar icon Published on

by Radu Tyrsina 

published on

Share this article

Readers help support Windows Report. We may get a commission if you buy through our links. Tooltip Icon

Read our disclosure page to find out how can you help Windows Report sustain the editorial team. Read more

Microsoft is partnering with Novartis, as Switzerland based pharmaceutical company, to use use artificial intelligence to improve drug discovery. The company aims to use AI to enhance research into developing new treatments for many of the health issues that are still without a cure.

Microsoft says that the partnership will help provide solutions to challenges when it comes to drug development, including research, trials, manufacturing, and even finance. The two companies can also address other challenges such as increasing the efficiency of analyzing huge sums of data and allow associates to easily share each others’ work.

In the announcement video, Microsoft CEO Satya Nadella explains:

“That’s why I’m so optimistic about this strategic partnership we’re announcing today with Novartis, which brings together the life sciences expertise with the power of Azure and Microsoft AI. Together we will work to answer some of the most challenging questions facing the life sciences industry today.”

Data scientists from Microsoft will work with Novartis research teams to investigate new ways on how AI can be used in three different areas. The first is to address challenges for personal treatment for macular degeneration, a disease that leads to irreversible blindness. Second, the companies want to look into using AI to increase the efficiency of manufacturing new gene and cell therapies for those with acute lymphoblastic leukemia. And lastly, they will work on ways to use neural networks to generate, screen, and select promising models to help improve the time it takes to create new medicines.

In addition to this partnership, Microsoft also worked with Novartis in 2016 in the past to help doctors access multiple sclerosis using the Kinect. The more recent partnership definitely makes a lot of sense, especially as Microsoft pushes to try to be the leader when it comes to AI advancements.

What do you think of the partnership? Feel free to drop a comment down below.

Radu Tyrsina

Radu Tyrsina Shield

Radu Tyrsina has been a Windows fan ever since he got his first PC, a Pentium III (a monster at that time). For most of the kids of his age, the Internet was an amazing way to play and communicate with others, but he was deeply impressed by the flow of information and how easily you can find anything on the web. Prior to founding Windows Report, this particular curiosity about digital content enabled him to grow a number of sites that helped hundreds of millions reach faster the answer they're looking for.

User forum

0 messages